These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17056201)

  • 21. Interstitial fluid pressure as a prognostic factor in cervical cancer following radiation therapy.
    Yeo SG; Kim JS; Cho MJ; Kim KH; Kim JS
    Clin Cancer Res; 2009 Oct; 15(19):6201-7. PubMed ID: 19773374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Celecoxib up-regulates the expression of the zeta chain of T cell receptor complex in tumor-infiltrating lymphocytes in human cervical cancer.
    Ferrandina G; Ranelletti FO; Legge F; Salutari V; Martinelli E; Fattorossi A; Lorusso D; Zannoni G; Vellone V; Paglia A; Scambia G
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2055-60. PubMed ID: 16609015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase I clinical trial of nasopharyngeal radiotherapy and concurrent celecoxib for patients with locoregionally advanced nasopharyngeal carcinoma.
    Xue WP; Bai SM; Luo M; Bi ZF; Liu YM; Wu SK
    Oral Oncol; 2011 Aug; 47(8):753-7. PubMed ID: 21708478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of the tumor microenvironment in cervix cancer using dynamic contrast enhanced CT, interstitial fluid pressure and oxygen measurements.
    Haider MA; Milosevic M; Fyles A; Sitartchouk I; Yeung I; Henderson E; Lockwood G; Lee TY; Roberts TP
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1100-7. PubMed ID: 15990015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. uPA is upregulated by high dose celecoxib in women at increased risk of developing breast cancer.
    Qin W; Zhu W; Hewett JE; Rottinghaus G; Chen YC; Flynn JT; Kliethermes B; Mannello F; Sauter ER
    BMC Cancer; 2008 Oct; 8():298. PubMed ID: 18922176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study.
    Nery FG; Monkul ES; Hatch JP; Fonseca M; Zunta-Soares GB; Frey BN; Bowden CL; Soares JC
    Hum Psychopharmacol; 2008 Mar; 23(2):87-94. PubMed ID: 18172906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Feasibility of RNA collection for micro-array gene expression analysis in the treatment of cervical carcinoma: a scientific correlate of RTOG C-0128.
    Gaffney DK; Winter K; Fuhrman C; Flinner R; Greven K; Ryu J; Forbes A; Kerlin K; Nichols RC; Zempolich K
    Gynecol Oncol; 2005 May; 97(2):607-11. PubMed ID: 15863167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cutaneous and intra-abdominal abscess formation in rats following radio frequency [corrected] ablation of liver tumors in combination with celecoxib treatment.
    De Heer P; Sandel MH; Speetjens FM; Koudijs MM; Putter H; Ensink GN; Van de Velde CJ; Kuppen PJ
    In Vivo; 2006; 20(3):373-5. PubMed ID: 16724673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bleeding complications in patients on celecoxib and warfarin.
    Chung L; Chakravarty EF; Kearns P; Wang C; Bush TM
    J Clin Pharm Ther; 2005 Oct; 30(5):471-7. PubMed ID: 16164494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective randomized trial on the role of perioperative celecoxib administration for total knee arthroplasty: improving clinical outcomes.
    Reuben SS; Buvenandran A; Katz B; Kroin JS
    Anesth Analg; 2008 Apr; 106(4):1258-64, table of contents. PubMed ID: 18349203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemopreventive effect of celecoxib in gastric cancer.
    Futagami S; Suzuki K; Hiratsuka T; Shindo T; Hamamoto T; Ueki N; Kusunoki M; Miyake K; Gudis K; Tsukui T; Sakamoto C
    Inflammopharmacology; 2007 Feb; 15(1):1-4. PubMed ID: 17323186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Celecoxib in the management of acute renal colic: a randomized controlled clinical trial.
    Phillips E; Hinck B; Pedro R; Makhlouf A; Kriedberg C; Hendlin K; Monga M
    Urology; 2009 Nov; 74(5):994-9. PubMed ID: 19589565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biologic markers of angiogenesis: circulating endothelial cells in patients with advanced malignancies treated on phase I protocol with metronomic chemotherapy and celecoxib.
    Twardowski PW; Smith-Powell L; Carroll M; VanBalgooy J; Ruel C; Frankel P; Synold TW
    Cancer Invest; 2008 Feb; 26(1):53-9. PubMed ID: 18181046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma levels of vascular endothelial growth factor during and after radiotherapy in combination with celecoxib in patients with advanced head and neck cancer.
    Halamka M; Cvek J; Kubes J; Zavadova E; Kominek P; Horacek J; Dusek L; Feltl D
    Oral Oncol; 2011 Aug; 47(8):763-7. PubMed ID: 21696999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thromboembolic cardiovascular risk among arthritis patients using cyclooxygenase-2-selective inhibitor or nonselective cyclooxygenase inhibitor nonsteroidal anti-inflammatory drugs.
    Spalding WM; Reeves MJ; Whelton A
    Am J Ther; 2007; 14(1):3-12. PubMed ID: 17303969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Celecoxib plus aspirin versus naproxen and lansoprazole plus aspirin: a randomized, double-blind, endoscopic trial.
    Goldstein JL; Cryer B; Amer F; Hunt B
    Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1167-74. PubMed ID: 17916545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized trial of a 6-week course of celecoxib on proteinuria in diabetic kidney disease.
    Sinsakul M; Sika M; Rodby R; Middleton J; Shyr Y; Chen H; Han E; Lehrich R; Clyne S; Schulman G; Harris R; Lewis J
    Am J Kidney Dis; 2007 Dec; 50(6):946-51. PubMed ID: 18037095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Questions #6. Does celecoxib increase cardiovascular risk?
    Mayer BJ; Lamfers R; Feldstein DA
    WMJ; 2005 Nov; 104(8):15-6. PubMed ID: 16425910
    [No Abstract]   [Full Text] [Related]  

  • 39. Celecoxib for treatment of nocturia caused by benign prostatic hyperplasia: a prospective, randomized, double-blind, placebo-controlled study.
    Falahatkar S; Mokhtari G; Pourreza F; Asgari SA; Kamran AN
    Urology; 2008 Oct; 72(4):813-6. PubMed ID: 18692876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preoperative concurrent radiation therapy and chemotherapy for bulky stage IB2, IIA, and IIB carcinoma of the uterine cervix with proximal parametrial invasion.
    Huguet F; Cojocariu OM; Levy P; Lefranc JP; Darai E; Jannet D; Ansquer Y; Lhuillier PE; Benifla JL; Seince N; Touboul E
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1508-15. PubMed ID: 18676093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.